Literature DB >> 1312815

White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome.

C S Lau1, A O'Dowd, J J Belch.   

Abstract

Systemic sclerosis (SSc) and vibration induced white finger syndrome (VWF) are common causes of secondary Raynaud's phenomenon. Previous studies have suggested an increase in inflammation in patients with SSc. Vibration induced white finger syndrome occurs in workers exposed to vibration and is now a prescribed disease. In VWF, although it is recognised that vibration can cause direct damage to blood vessels, it does not explain why only some workers are affected. It is possible that an inflammatory process develops in these patients in the same way as is seen in SSc. Leukotriene B4, produced mainly by polymorphonuclear cells, is a potent mediator of inflammation. The plasma thiol concentration shows the degree of oxidation of plasma and a decreased concentration indicates the increased production of free radicals which are capable of oxidative damage. In this work, the white blood cell (WBC) production of leukotriene B4 and plasma thiol concentrations were measured in patients with SSc and VWF. Fifty nine patients were studied: 34 had SSc and 25 had VWF. The results were compared with 25 matched normal controls and are expressed as the median and range. After stimulation of the polymorphonuclear cells with calcium ionophore A23187 (1 microgram/ml), patients with SSc and VWF were found to have significantly increased leukotriene B4 production (23.5 (14.4-44.0) and 26 (14.4-39.4) ng/10(6) cells, respectively) compared with normal controls (17.2 (6.0-38.0) ng/10(6) cells). The plasma thiol concentration was shown to be significantly lower in patients with SSc and VWF (445 (375-475) and 450 (417-510) mumol/l, respectively) compared with normal controls (480 (418-555) mumol/l). Our results show increased leukotriene B4 production and increased free radical activity in patients with SSc and VWF. Although previous indirect evidence has suggested increased WBC activity in patients with SSc, this is reported directly here for the first time. In addition, the possibility of an inflammatory process occurring in patients with VWF, as shown here, has not previously been studied. This may be a further mechanism to explain the poor circulation in the fingers of these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312815      PMCID: PMC1005668          DOI: 10.1136/ard.51.2.249

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

Review 2.  A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

Authors:  E C Leroy; E A Smith; M B Kahaleh; M Trojanowska; R M Silver
Journal:  Arthritis Rheum       Date:  1989-07

3.  Serum sulfhydryl groups in rheumatoid arthritis.

Authors:  M Haataja; J L Kalliomäki
Journal:  Z Rheumatol       Date:  1977 Mar-Apr       Impact factor: 1.372

4.  Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma.

Authors:  A Akesson; F A Wollheim
Journal:  Br J Rheumatol       Date:  1989-08

5.  An approach to free radicals in medicine and biology.

Authors:  R F Del Maestro
Journal:  Acta Physiol Scand Suppl       Date:  1980

6.  Altered thiol status in patients with rheumatoid arthritis.

Authors:  J C Banford; D H Brown; R A Hazelton; C J McNeil; W E Smith; R D Sturrock
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

7.  Leukocyte migration and phagocytosis in progressive systemic sclerosis.

Authors:  S Spisani; L Dovigo; V Colamussi
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

8.  Human whole-blood granulocyte aggregation in vitro.

Authors:  T C Fisher; J J Belch; J C Barbenel; A C Fisher
Journal:  Clin Sci (Lond)       Date:  1989-02       Impact factor: 6.124

9.  Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.

Authors:  M B Kahaleh; I Osborn; E C LeRoy
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

10.  Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis.

Authors:  C L Maslen; N D Hall; A D Woolf; P J Maddison
Journal:  Br J Rheumatol       Date:  1987-04
View more
  11 in total

1.  Vibration exposure, smoking, and vascular dysfunction.

Authors:  M Cherniack; J Clive; A Seidner
Journal:  Occup Environ Med       Date:  2000-05       Impact factor: 4.402

2.  Macrovascular disease and systemic sclerosis.

Authors:  M Ho; D Veale; C Eastmond; G Nuki; J Belch
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

Review 3.  Pharmacotherapy of Raynaud's phenomenon.

Authors:  J J Belch; M Ho
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

4.  Influence of nifedipine on plasma membrane fluidity and oxidative burst of polymorphonuclear leucocytes.

Authors:  W Grassi; R Serretti; P Core; S Muti; C Cervini
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

5.  Extracellular signal-regulated kinase activation and endothelin-1 production in human endothelial cells exposed to vibration.

Authors:  Charles R White; Mark A Haidekker; Hazel Y Stevens; John A Frangos
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

6.  Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis.

Authors:  Valeria Riccieri; Antonio Spadaro; Leos Fuksa; Omidreza Firuzi; Luciano Saso; Guido Valesini
Journal:  Clin Rheumatol       Date:  2007-10-27       Impact factor: 2.980

Review 7.  Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopy.

Authors:  Anna Kuryliszyn-Moskal; Jacek Kita; Anna Hryniewicz
Journal:  Reumatologia       Date:  2015-05-18

Review 8.  The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy.

Authors:  Amaal E Abdulle; Gilles F H Diercks; Martin Feelisch; Douwe J Mulder; Harry van Goor
Journal:  Front Physiol       Date:  2018-08-24       Impact factor: 4.566

9.  Rapid free thiol rebound is a physiological response following cold-induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosis.

Authors:  Amaal Eman Abdulle; Anniek M van Roon; Andries J Smit; Andreas Pasch; Matijs van Meurs; Hendrika Bootsma; Stephan J L Bakker; Mohammad Y Said; Bernadette O Fernandez; Martin Feelisch; Harry van Goor; Douwe J Mulder
Journal:  Physiol Rep       Date:  2019-03

10.  Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.

Authors:  Gianluca Bagnato; Alessandra Bitto; Natasha Irrera; Gabriele Pizzino; Donatella Sangari; Maurizio Cinquegrani; William Roberts; Marco Atteritano; Domenica Altavilla; Francesco Squadrito; Gianfilippo Bagnato; Antonino Saitta
Journal:  Arthritis Res Ther       Date:  2013-09-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.